What’s Trending on PharmPro.com
Popular Blood Pressure Med Linked To Increased Risk of
Danish researchers set their sights on antihypertensive medicine containing
hydrochlorothiazide, due to an increased risk for skin cancer.
FDA Accepts New Drug Application For Treatment Of Rare
Progenics Pharmaceuticals’ Azedra was accepted for review in patients
with malignant, recurrent, and/or unresectable pheochromocytoma and
paraganglioma, which are rare neuroendocrine tumors.
FDA Issues Warning Over
Gadolinium-Based Contrast Agents
The agency warned that gadolinium used
in MRI contrast agents remains in patients’
bodies, including the brain, for months to years,
but concluded that the benefit continues to
outweigh potential risks.
People on the Move
Hal Barron, formerly with Calico Life Sciences, joined GlaxoSmithKline
as head of R&D • Laura Hamilton moved from Massachusetts
Biotechnology Council to RxCelerate, Cambridge, Mass., as executive VP •
Michael Rogers, previously CFO at Acorda Therapeutics, appointed CFO
of Aerpio Pharmaceuticals, Inc., Cincinnati, Ohio • Elizabeth Iorns, Ph.D.,
CEO of Science Exchange, Palo Alto, Calif., was elected to the board of
directors of the Drug, Chemical & Associated Technologies Association
• Mike Burgess, MBChB, Ph.D., named president of R&D at Turnstone
Biologics, joining from Bristol-Myers Squibb, where he was a senior VP
of development • Albert Bourla was named COO at Pfizer. He has
served as group president of Pfizer’s Innovative Health Business since the
beginning of 2016 • Marie-Paule Richard and Gilles Alberici, PharmD,
were appointed to the supervisory board of biotechnology company
Nosopharm, Lyon, France • Chris Brown joined Domainex Ltd., as chief
financial officer. • Martin Naley, founding CEO of Cure Forward, was
appointed head of
U.S. operations at
and Pharma Issues
"On one path are those physicians who continue to
practice quality medicine, and on the other are those
who just see this as a way of making a lot of money."
—Dr. David Bearman, commenting to Associated
Press in an article on the practice of prescribing
medical marijuana in California.
Feb. 26-March 1
This annual conference and exposition
for laboratory science shines a light on
new technology and scientific research in
pharmaceutical science and more.
Smart Manufacturing Leaders Summit
Join more than 120 senior manufacturing
decision makers in biotech, automotive,
aerospace, defense, chemicals, medtech,
and FMCG industries to help solve strategic
Inhalation & Respiratory Drug Delivery
San Diego, CA
More than 200 senior industry experts will
present new trends in combination product
design and the future directions of inhalation
drug delivery research.
Drug Discovery 2018
The second annual conference on Drug
Discovery will bring together key opinion leaders
and senior industry experts to discuss the latest
developments in drug discovery strategies.
The International Pharmaceutical Conference
and Expo offers business, research
opportunities, and access to new markets in
the pharma and health care industries.
World Vaccine Congress
Research, development, and strategic partnering
for the global vaccine industry.
New York, NY
The premier pharmaceutical, biotechnology, and
device development and manufacturing event
where attendees can “Experience Science
PHARMACEUTICAL PROCESSING 27
The number of workers
worldwide that Teva
Pharmaceuticals intends to
let go as part of a broader
restructuring and cost-cutting
strategy. Teva, the world’s
largest generic drugmaker was
hit hard when patents for its
blockbuster drug, Copaxone,
expired in early 2017.